1. Home
  2. RADX
  3. RADX News

Latest RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD (RADX) News on June 22, 2025

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases
RADX

GlobeNewswire

11 days ago

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
RADX

GlobeNewswire

18 days ago

Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake
RADX

GlobeNewswire

20 days ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Independent Non-Executive Director of Radiopharm Theranostics Picks Up 48% More Stock
RADX

Simply Wall St.

20 days ago

Independent Non-Executive Director of Radiopharm Theranostics Picks Up 48% More Stock

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
RADX

GlobeNewswire

a month ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)
RADX

GlobeNewswire

a month ago

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)

RADX: Initiating Coverage – Adding a Radioisotope to Precision Oncology
RADX

Zacks Small Cap Research

a month ago

RADX: Initiating Coverage – Adding a Radioisotope to Precision Oncology

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference
RADX

GlobeNewswire

a month ago

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

RADX

GlobeNewswire

2 months ago

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution
RADX

GlobeNewswire

3 months ago

New RAD202 Data Confirms Positive Tumor Uptake and Favorable Biodistribution

Positive Signs As Multiple Insiders Buy Radiopharm Theranostics Stock
RADX

Simply Wall St.

4 months ago

Positive Signs As Multiple Insiders Buy Radiopharm Theranostics Stock

New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases
RADX

GlobeNewswire

4 months ago

New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement
RADX

GlobeNewswire

5 months ago

Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia
RADX

GlobeNewswire

6 months ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial
RADX

GlobeNewswire

6 months ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Share on Social Networks: